|
1
|
Abel EV and Simeone DM: Biology and
clinical applications of pancreatic cancer stem cells.
Gastroenterology. 144:1241–1248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGuire S: World cancer report 2014.
Geneva, Switzerland: World health organization, international
agency for research on cancer, WHO press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ansari D, Tingstedt B, Andersson B,
Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M
and Andersson R: Pancreatic cancer: Yesterday, today and tomorrow.
Future Oncol. 12:1929–1946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shin SJ, Park H, Sung YN, Yoo C, Hwang DW,
Park JH, Kim KP, Lee SS, Ryoo BY, Seo DW, et al: Prognosis of
pancreatic cancer patients with synchronous or metachronous
malignancies from other organs is better than those with pancreatic
cancer only. Cancer Res Treat. 50:1175–1185. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han Q, Li J, Xiong J and Song Z: Long
noncoding RNA LINC00514 accelerates pancreatic cancer progression
by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. J
Exp Clin Cancer Res. 39:1512020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Halbrook CJ and Lyssiotis CA: Employing
metabolism to improve the diagnosis and treatment of pancreatic
cancer. Cancer Cell. 31:5–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei JW, Huang K, Yang C and Kang CS:
Non-coding RNAs as regulators in epigenetics (Review). Oncol Rep.
37:3–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dykes IM and Emanueli C: Transcriptional
and post-transcriptional gene regulation by long non-coding RNA.
Genomics Proteomics Bioinformatics. 15:177–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao Y, Xiong JB, Zhang GY, Liu Y, Jie ZG
and Li RZ: Long noncoding RNA UCA1 regulates PRL-3 expression by
sponging microRNA-495 to promote the progression of gastric cancer.
Mol Ther Nucleic Acids. 19:853–864. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L,
Hao Y, Vladimir BO and Jia L: Circulating lncRNA UCA1 promotes
malignancy of colorectal cancer via the miR-143/MYO6 axis. Mol Ther
Nucleic Acids. 19:790–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malik SS, Zia A, Mubarik S, Masood N,
Rashid S, Sherrard A, Khan MB and Khadim MT: Correlation of MLH1
polymorphisms, survival statistics, in silico assessment and gene
downregulation with clinical outcomes among breast cancer cases.
Mol Biol Rep. 47:683–692. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan S, Shen M, Zhou M, Shi X, He R, Yin T,
Wang M, Guo X and Qin R: Long noncoding RNA LINC01111 suppresses
pancreatic cancer aggressiveness by regulating DUSP1 expression via
microRNA-3924. Cell Death Dis. 10:8832019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lei S, He Z, Chen T, Guo X, Zeng Z, Shen Y
and Jiang J: Long noncoding RNA 00976 promotes pancreatic cancer
progression through OTUD7B by sponging miR-137 involving EGFR/MAPK
pathway. J Exp Clin Cancer Res. 38:4702019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang
Q and Wu H: LncRNA H19/miR-194/PFTK1 axis modulates the cell
proliferation and migration of pancreatic cancer. J Cell Biochem.
120:3874–3886. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong MM, Peng SJ, Yuan YN and Luo HP:
LncRNA TTN-AS1 contributes to gastric cancer progression by acting
as a competing endogenous RNA of miR-376b-3p. Neoplasma.
66:564–575. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui Z, Luo Z, Lin Z, Shi L, Hong Y and Yan
C: Long non-coding RNA TTN-AS1 facilitates tumorigenesis of
papillary thyroid cancer through modulating the miR-153-3p/ZNRF2
axis. J Gene Med. 21:e30832019. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen P, Wang R, Yue Q and Hao M: Long
non-coding RNA TTN-AS1 promotes cell growth and metastasis in
cervical cancer via miR-573/E2F3. Biochem Biophys Res Commun.
503:2956–2962. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Y, Huang Y, Dai T, Hua Z, Xu J, Lin
Y, Han L, Yue X, Ho L, Lu J and Ai X: LncRNA TTN-AS1 intensifies
sorafenib resistance in hepatocellular carcinoma by sponging
miR-16-5p and upregulation of cyclin E1. Biomed Pharmacother.
133:1110302021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia Y, Duan Y, Liu T, Wang X, Lv W, Wang
M, Wang J and Liu L: LncRNA TTN-AS1 promotes migration, invasion,
and epithelial mesenchymal transition of lung adenocarcinoma via
sponging miR-142-5p to regulate CDK5. Cell Death Dis. 10:5732019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu SW, Zhang Y, Li S, Shi ZY, Zhao J and
He QL: LncRNA TTN-AS1 promotes the progression of oral squamous
cell carcinoma via miR-411-3p/NFAT5 axis. Cancer Cell Int.
20:4152020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng H, Wang Q, Xiao W, Zhang B, Jin Y and
Lu H: LncRNA TTN-AS1 regulates miR-524-5p and RRM2 to promote
breast cancer progression. Onco Targets Ther. 13:4799–4811. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang W, Lou W, Ding B, Yang B, Lu H, Kong
Q and Fan W: A novel mRNA-miRNA-lncRNA competing endogenous RNA
triple sub-network associated with prognosis of pancreatic cancer.
Aging (Albany NY). 11:2610–2627. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai XN, Li J, Tang LB, Chen WT, Zhang L
and Xiong LX: MiRNAs and LncRNAs: Dual roles in TGF-β
signaling-regulated metastasis in lung cancer. Int J Mol Sci.
21:11932020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang C, Tan C, Wen Y, Zhang D, Li G, Chang
L, Su J and Wang X: FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor
suppressor in pituitary prolactinoma by repressing the autophagy
via inactivating Wnt/β-catenin signaling pathway. Cell Death Dis.
10:4992019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong T, Li Y, Feng L, Fang MZ, Dai G,
Huang X, Yang Y and Liu S: CASC21, a FOXP1 induced long non-coding
RNA, promotes colorectal cancer growth by regulating CDK6. Aging
(Albany NY). 12:12086–12106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan J, Jia Y, Chen H, Chen W and Zhou X:
Long non-coding RNA PXN-AS1 suppresses pancreatic cancer
progression by acting as a competing endogenous RNA of miR-3064 to
upregulate PIP4K2B expression. J Exp Clin Cancer Res. 38:3902019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao GW, Bai JR and Zhang DP: P21 activated
kinase 2 promotes pancreatic cancer growth and metastasis. Oncol
Lett. 17:3709–3718. 2019.PubMed/NCBI
|
|
33
|
Dugimont T, Curgy JJ, Wernert N, Delobelle
A, Raes MB, Joubel A, Stehelin D and Coll J: The H19 gene is
expressed within both epithelial and stromal components of human
invasive adenocarcinomas. Biol Cell. 85:117–124. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Verkerk AJ, Ariel I, Dekker MC, Schneider
T, van Gurp RJ, de Groot N, Gillis AJ, Oosterhuis JW, Hochberg AA
and Looijenga LH: Unique expression patterns of H19 in human
testicular cancers of different etiology. Oncogene. 14:95–107.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tahira AC, Kubrusly MS, Faria MF, Dazzani
B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado
MCC and Reis EM: Long noncoding intronic RNAs are differentially
expressed in primary and metastatic pancreatic cancer. Mol Cancer.
10:1412011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu D, Han GH, Zhao X, Liu X, Xue K, Wang D
and Xu CB: MicroRNA-129-5p suppresses nasopharyngeal carcinoma
lymphangiogenesis and lymph node metastasis by targeting ZIC2. Cell
Oncol (Dordr). 43:249–261. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fellenberg J, Lehner B, Saehr H, Schenker
A and Kunz P: Tumor suppressor function of miR-127-3p and
miR-376a-3p in osteosarcoma cells. Cancers (Basel). 11:20192019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo S, Fesler A, Huang W, Wang Y, Yang J,
Wang X, Zheng Y, Hwang GR, Wang H and Ju J: Functional significance
and therapeutic potential of miR-15a mimic in pancreatic ductal
adenocarcinoma. Mol Ther Nucleic Acids. 19:228–239. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Georgikou C, Yin L, Gladkich J, Xiao X,
Sticht C, de la Torre C, Gretz N, Gross W, Schäfer M, Karakhanova S
and Herr I: Inhibition of miR30a-3p by sulforaphane enhances gap
junction intercellular communication in pancreatic cancer. Cancer
Lett. 469:238–245. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Y, Dong L and Liu Y: Targeting
thyroid receptor interacting protein 6 by MicroRNA-589-5p inhibits
cell proliferation, migration, and invasion in endometrial
carcinoma. Cancer Biother Radiopharm. 34:529–536. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhu Q, Luo Z, Lu G, Gui F, Wu J, Li F and
Ni Y: LncRNA FABP5P3/miR-589-5p/ZMYND19 axis contributes to
hepatocellular carcinoma cell proliferation, migration and
invasion. Biochem Biophys Res Commun. 498:551–558. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu H, Wang B, Borde M, Nardone J, Maika S,
Allred L, Tucker PW and Rao A: Foxp1 is an essential
transcriptional regulator of B cell development. Nat Immunol.
7:819–826. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Craig VJ, Cogliatti SB, Imig J, Renner C,
Neuenschwander S, Rehrauer H, Schlapbach R, Dirnhofer S, Tzankov A
and Müller A: Myc-mediated repression of microRNA-34a promotes
high-grade transformation of B-cell lymphoma by dysregulation of
FoxP1. Blood. 117:6227–6236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu B, Zhou X, Li B, Xiao X, Yan S and Shi
D: FOXP1 expression and its clinicopathologic significance in nodal
and extranodal diffuse large B-cell lymphoma. Ann Hematol.
90:701–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sagaert X, de Paepe P, Libbrecht L,
Vanhentenrijk V, Verhoef G, Thomas J, Wlodarska I and De
Wolf-Peeters C: Forkhead box protein P1 expression in
mucosa-associated lymphoid tissue lymphomas predicts poor prognosis
and transformation to diffuse large B-cell lymphoma. J Clin Oncol.
24:2490–2497. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wu M, Huang Y, Chen T, Wang W, Yang S, Ye
Z and Xi X: LncRNA MEG3 inhibits the progression of prostate cancer
by modulating miR-9-5p/QKI-5 axis. J Cell Mol Med. 23:29–38. 2019.
View Article : Google Scholar : PubMed/NCBI
|
